Halozyme Therapeutics Inc (NAS:HALO)
$ 38.77 0.2 (0.52%) Market Cap: 4.93 Bil Enterprise Value: 6.09 Bil PE Ratio: 18.37 PB Ratio: 58.65 GF Score: 83/100

Halozyme Therapeutics Inc (HALO) Stock Estimates Data

Halozyme Therapeutics Inc (HALO) 12 Month Price Targets

Halozyme Therapeutics Inc (HALO) Analyst Rating